Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Card Surg ; 36(1): 381-383, 2021 Jan.
Article in English | MEDLINE | ID: mdl-33111997

ABSTRACT

Left ventricular assist devices (LVADs) have become integral to the treatment of advanced heart failure. Surgical bleeding is a known complication of LVAD placement but is most associated with intraperitoneal pump locations. Here we describe a case of massive postoperative hemorrhage secondary to erosion of an intrapericardial LVAD into an intercostal artery with an associated rib fracture.


Subject(s)
Heart Failure , Heart-Assist Devices , Heart Failure/etiology , Heart Failure/therapy , Heart-Assist Devices/adverse effects , Humans , Postoperative Hemorrhage , Retrospective Studies
2.
Ann N Y Acad Sci ; 1461(1): 53-72, 2020 02.
Article in English | MEDLINE | ID: mdl-30937918

ABSTRACT

Obesity is the major contributing factor for the increased prevalence of type 2 diabetes (T2D) in recent years. Sustained positive influx of lipids is considered to be a precipitating factor for beta cell dysfunction and serves as a connection between obesity and T2D. Importantly, fatty acids (FA), a key building block of lipids, are a double-edged sword for beta cells. FA acutely increase glucose-stimulated insulin secretion through cell-surface receptor and intracellular pathways. However, chronic exposure to FA, combined with elevated glucose, impair the viability and function of beta cells in vitro and in animal models of obesity (glucolipotoxicity), providing an experimental basis for the propensity of beta cell demise under obesity in humans. To better understand the two-sided relationship between lipids and beta cells, we present a current view of acute and chronic handling of lipids by beta cells and implications for beta cell function and health. We also discuss an emerging role for lipid droplets (LD) in the dynamic regulation of lipid metabolism in beta cells and insulin secretion, along with a potential role for LD under nutritional stress in beta cells, and incorporate recent advancement in the field of lipid droplet biology.


Subject(s)
Diabetes Mellitus, Type 2/metabolism , Insulin Secretion , Islets of Langerhans/metabolism , Lipid Metabolism , Animals , Glucose/metabolism , Humans , Insulin Secretion/drug effects , Islets of Langerhans/drug effects , Lipid Metabolism/drug effects , Lipids/toxicity
3.
J Vasc Surg ; 67(3): 838-847, 2018 03.
Article in English | MEDLINE | ID: mdl-29276109

ABSTRACT

OBJECTIVE: The objective of this study was to determine the natural progression of popliteal artery aneurysms (PAAs) and clinical variables associated with their accelerated growth. METHODS: Retrospective chart review of 224 patients with encounters between January 2008 and May 2016 and with at least one PAA was conducted. From this group, 65 asymptomatic patients had either unilateral (n = 43) or bilateral (n = 22) PAAs that were observed for at least 1 year of medical management before intervention. We divided these aneurysms into two groups based on whether their overall growth rate was above or below the eventual mean. Aneurysm diameter was taken from duplex ultrasound and computed tomography angiography. RESULTS: There were 87 aneurysms evaluated among 65 patients. Mean age at diagnosis was 70.9 years (standard deviation [SD], 9.39 years), and 64 patients were male (98%); 50 (77%) were white and 7 (11%) were African American. The average body mass index was 27.69 (SD, 4.90). At or before initial diagnosis, 61 (94%) patients had a concomitant lower extremity or abdominal aortic aneurysm; 51 (78%) patients were current or former smokers; and 16 (25%) had atrial fibrillation. The average growth rate of all aneurysms was 1.22 mm/y (SD, 1.93 mm). The mean surveillance time from initial diagnosis to last follow-up or intervention was 3.12 years (SD, 1.66 years). Of 87 aneurysms, 25 (29%) were repaired; 18 (21%) were repaired because of size criteria, 2 (2%) because of symptom criteria (claudication or acute limb ischemia), and 5 (6%) because of both criteria. During our study window, 62 aneurysms (71%) remained asymptomatic or did not undergo an intervention. The mean initial diameter at diagnosis was 16.9 mm (SD, 5.32 mm). Within the study, 50 (57%) aneurysms presented with or developed mural thrombus. Univariate analysis identified larger initial diameter (19.2 vs 14.7 mm; P = .020), atrial fibrillation (35% vs 16%; P = .042), and mural thrombus (38% vs 20%; P < .001) as predictors of diameter expansion greater than the mean. Multivariable analysis of the significant univariate factors determined that only initial diameter (odds ratio, 5.53; P = .007) and the presence or development of mural thrombus (odds ratio, 4.00; P = .008) maintained significance. CONCLUSIONS: Patients presenting with a PAA at 20 mm or >20 mm in diameter, presence of luminal thrombus, or atrial fibrillation may need to be observed at more frequent scanning intervals than those without these risk factors. Further studies are required to validate these predictive growth factors.


Subject(s)
Aneurysm/epidemiology , Popliteal Artery , Thrombosis/epidemiology , Aged , Aneurysm/diagnostic imaging , Aneurysm/therapy , Asymptomatic Diseases , Chi-Square Distribution , Comorbidity , Computed Tomography Angiography , Disease Progression , Female , Humans , Logistic Models , Male , Middle Aged , Multivariate Analysis , Odds Ratio , Popliteal Artery/diagnostic imaging , Popliteal Artery/surgery , Retrospective Studies , Risk Factors , Thrombosis/diagnostic imaging , Thrombosis/therapy , Time Factors , Ultrasonography, Doppler, Duplex , Virginia/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...